BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1128 related articles for article (PubMed ID: 16434941)

  • 1. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
    King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
    Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.
    Yamaki T; Hamahata A; Soejima K; Kono T; Nozaki M; Sakurai H
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):343-7. PubMed ID: 22230599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
    Jimenez JC; Lawrence PF; Woo K; Chun TT; Farley SM; Rigberg DA; Baril DT; Derubertis BG
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):904-909. PubMed ID: 33248297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe chronic venous insufficiency treated by foamed sclerosant.
    Pascarella L; Bergan JJ; Mekenas LV
    Ann Vasc Surg; 2006 Jan; 20(1):83-91. PubMed ID: 16378144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous angiomata: treatment with sclerosant foam.
    Pascarella L; Bergan JJ; Yamada C; Mekenas L
    Ann Vasc Surg; 2005 Jul; 19(4):457-64. PubMed ID: 15981122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
    Gonzalez-Zeh R; Armisen R; Barahona S
    J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series.
    Davis PE; Phillips J; Kolluri R
    Ann Vasc Surg; 2018 Oct; 52():176-182. PubMed ID: 29772321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes.
    Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K;
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovenous laser ablation and foam sclerotherapy for varicose veins: does the presence of perforating vein insufficiency affect the treatment outcome?
    Köroglu M; Eris HN; Aktas AR; Kayan M; Yeşildağ A; Cetin M; Parlak C; Gürses C; Akhan O
    Acta Radiol; 2011 Apr; 52(3):278-84. PubMed ID: 21498363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the treatment of the small saphenous veins with foam sclerotherapy at risk of deep vein thrombosis?
    Gillet JL; Lausecker M; Sica M; Guedes JM; Allaert FA
    Phlebology; 2014 Oct; 29(9):600-7. PubMed ID: 23864534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
    Yamaki T; Nozaki M; Iwasaka S
    Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Combining Saphenous Endovenous Laser Ablation and Varicose Veins Foam Sclerotherapy: An Analysis on 5500 Procedures in Patients With Advance Chronic Venous Disease (C3-C6).
    Baraldi C; Bissacco D
    Vasc Endovascular Surg; 2024 Jan; 58(1):60-64. PubMed ID: 37430384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
    Kölbel T; Hinchliffe RJ; Lindblad B
    Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
    Baeshko A; Shestak N; Korytko S
    Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®.
    Vun SV; Rashid ST; Blest NC; Spark JI
    Phlebology; 2015 Dec; 30(10):688-92. PubMed ID: 25300311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.